SINOPHARM GROUP CO LTD ADR
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $13.85
- Today's High:
- $14.01
- Open Price:
- $14.01
- 52W Low:
- $8.9866
- 52W High:
- $17.3651
- Prev. Close:
- $13.25
- Volume:
- 10279
Company Statistics
- Market Cap.:
- $8.77 billion
- Book Value:
- 111.52
- Revenue TTM:
- $591.63 billion
- Operating Margin TTM:
- 3.91%
- Gross Profit TTM:
- $47.43 billion
- Profit Margin:
- 1.51%
- Return on Assets TTM:
- 3.67%
- Return on Equity TTM:
- 13.91%
Company Profile
SINOPHARM GROUP CO LTD ADR had its IPO on under the ticker symbol SHTDY.
The company operates in the Healthcare sector and Medical Distribution industry. SINOPHARM GROUP CO LTD ADR has a staff strength of 113,362 employees.
Stock update
Shares of SINOPHARM GROUP CO LTD ADR opened at $14.01 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $13.85 - $14.01, and closed at $13.87.
This is a +4.68% increase from the previous day's closing price.
A total volume of 10,279 shares were traded at the close of the day’s session.
In the last one week, shares of SINOPHARM GROUP CO LTD ADR have slipped by -4.15%.
SINOPHARM GROUP CO LTD ADR's Key Ratios
SINOPHARM GROUP CO LTD ADR has a market cap of $8.77 billion, indicating a price to book ratio of 0.8983 and a price to sales ratio of 0.0149.
In the last 12-months SINOPHARM GROUP CO LTD ADR’s revenue was $591.63 billion with a gross profit of $47.43 billion and an EBITDA of $25.11 billion. The EBITDA ratio measures SINOPHARM GROUP CO LTD ADR's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, SINOPHARM GROUP CO LTD ADR’s operating margin was 3.91% while its return on assets stood at 3.67% with a return of equity of 13.91%.
In Q3, SINOPHARM GROUP CO LTD ADR’s quarterly earnings growth was a positive 12.3% while revenue growth was a positive 16.1%.
SINOPHARM GROUP CO LTD ADR’s PE and PEG Ratio
- Forward PE
- 6.9396
- Trailing PE
- 7.0765
- PEG
- 50.9241
Its diluted EPS in the last 12-months stands at $1.96 per share while it has a forward price to earnings multiple of 6.9396 and a PEG multiple of 50.9241. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SINOPHARM GROUP CO LTD ADR’s profitability.
SINOPHARM GROUP CO LTD ADR stock is trading at a EV to sales ratio of 0.0315 and a EV to EBITDA ratio of 0.6686. Its price to sales ratio in the trailing 12-months stood at 0.0149.
SINOPHARM GROUP CO LTD ADR stock pays annual dividends of $0 per share, indicating a yield of 4.33% and a payout ratio of 29.03%.
Balance sheet and cash flow metrics
- Total Assets
- $364.78 billion
- Total Liabilities
- $234.96 billion
- Operating Cash Flow
- $-1406006517.00
- Capital Expenditure
- $602.37 million
- Dividend Payout Ratio
- 29.03%
SINOPHARM GROUP CO LTD ADR ended 2024 with $364.78 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $364.78 billion while shareholder equity stood at $68.07 billion.
SINOPHARM GROUP CO LTD ADR ended 2024 with $0 in deferred long-term liabilities, $234.96 billion in other current liabilities, 3120656000.00 in common stock, $0 in retained earnings and $7.16 billion in goodwill. Its cash balance stood at $55.22 billion and cash and short-term investments were $55.22 billion. The company’s total short-term debt was $54,633,193,000 while long-term debt stood at $11.75 billion.
SINOPHARM GROUP CO LTD ADR’s total current assets stands at $319.41 billion while long-term investments were $0 and short-term investments were $498000.00. Its net receivables were $155.58 billion compared to accounts payable of $144.62 billion and inventory worth $60.93 billion.
In 2024, SINOPHARM GROUP CO LTD ADR's operating cash flow was $-1406006517.00 while its capital expenditure stood at $602.37 million.
Comparatively, SINOPHARM GROUP CO LTD ADR paid $0.29 in dividends in 2024.
Other key metrics
- Current Trading Price
- $13.87
- 52-Week High
- $17.3651
- 52-Week Low
- $8.9866
- Analyst Target Price
- $
SINOPHARM GROUP CO LTD ADR stock is currently trading at $13.87 per share. It touched a 52-week high of $17.3651 and a 52-week low of $17.3651. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $14.49 and 200-day moving average was $14.2 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 3.8% are held by institutions.
Frequently Asked Questions About SINOPHARM GROUP CO LTD ADR
Similar Industry Stocks (Medical Distribution)
Most Active
Top Gainers
Top Losers
About
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People’s Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.